China Diabetes Care Devices Investment opportunities Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the China diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in China.
[Fade out the market survey infos]

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetes Care Devices 10
3.2 Glucose Monitoring 10
3.2.1 Blood Glucose Meter 10
3.2.2 Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Jet Injector 10
3.3.2 Insulin Pen 10
3.3.3 Insulin Pump 11
3.3.4 Insulin Syringes 11
4 Healthcare Sector Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure 13
4.2.1 Healthcare Personnel Data 14
4.2.2 Healthcare Facilities Data 15
4.3 Healthcare Policy 18
4.4 China Healthcare Trade Statistics 19
5 Regulation System 20
5.1 Medical Equipment Approval Process 20
5.1.1 Classification 20
5.1.2 Registration and Conformity assessment 21
5.1.3 China Compulsory Certificate (CCC Mark) 23
5.1.4 Labeling and Packaging 24
5.1.5 Registration Fee 25
5.1.6 Registration Period 25
5.2 Post Market Surveillance (PMS) 25
6 Pricing and Reimbursement 26
7 Distribution Structure 28
8 China Cross Market Comparison 29
9 Diabetes Care Devices Cross Country Comparison 31
10 Diabetes Care Devices in China 33
10.1 Diabetes Care Devices Overall Revenues by Category (2000-2012) 33
10.2 Diabetes Care Devices Overall Volume by Category (2000-2012) 37
10.3 Diabetes Care Devices Overall Company Share (2006-2007) 38
11 Glucose Monitoring in China 39
11.1 Glucose Monitoring Revenues by Segment (2000-2012) 39
11.2 Glucose Monitoring Volume by Segment (2000-2012) 41
11.3 Glucose Monitoring Average Price (2000-2012) 43
11.4 Glucose Monitoring Distribution Share (2006-2007) 44
11.5 Glucose Monitoring Company Share (2006-2007) 45
12 Insulin Delivery in China 46
12.1 Insulin Delivery Revenues by Segment (2000-2012) 46
12.2 Insulin Delivery Volume by Segment (2000-2012) 48
12.3 Insulin Delivery Average Price (2000-2012) 49
12.4 Insulin Delivery Distribution Share (2006-2007) 50
12.5 Insulin Delivery Company Share (2006-2007) 51
13 F. Hoffmann-La Roche Ltd. Company Profile 52
13.1 Company Overview 52
13.2 Value Chain Analysis 52
13.2.1 Manufacturing 53
13.2.2 Product Development 53
13.2.3 Sales and Marketing 54
14 Abbott Laboratories Strategic Analysis Profile 55
14.1 Company Overview 55
14.2 Value Chain Analysis 55
14.2.1 Manufacturing 56
14.2.2 Product Development 56
14.2.3 Sales and Marketing 57
14.3 Abbott Laboratories Pipeline Products 58
14.3.1 Abbott Laboratories Pipeline Products By Equipment Type 58
14.3.2 Abbott Laboratories Pipeline Products By Development Stage 58
14.3.3 Abbott Laboratories Pipeline Products By Therapy Area 58
14.3.4 Abbott Laboratories Pipeline Products By Clinical Trials 59
14.3.5 Abbott Laboratories Pipeline Products By News Summary 59
15 LifeScan, Inc. Company Profile 60
15.1 Company Overview 60
15.2 LifeScan, Inc. Pipeline Products 60
15.2.1 LifeScan, Inc. Pipeline Products by Equipment Type 60
15.2.2 LifeScan, Inc. Pipeline Products by Development Stage 60
15.2.3 LifeScan, Inc. Pipeline Products by Therapy Area 61
15.2.4 LifeScan, Inc. Pipeline Products by News Summary 61
16 Novo Nordisk A/S Company Profile 62
16.1 Company Overview 62
16.2 Novo Nordisk A/S Pipeline Products 62
16.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type 62
16.2.2 Novo Nordisk A/S Pipeline Products by Development Stage 62
16.2.3 Novo Nordisk A/S Pipeline Products by Therapy Area 62
17 Becton, Dickinson and Company Strategic Analysis Profile 63
17.1 Company Overview 63
17.2 Value Chain Analysis 63
17.2.1 Manufacturing 64
17.2.2 Product Development 64
17.2.3 Sales and Marketing 64
18 Appendix 65
18.1 Global Markets Direct Research Methodology 65
18.2 Coverage 66
18.3 Secondary Research 66
18.4 Primary Research 67
18.5 Models 67
18.6 Forecasts 68
18.7 Expert Panels 68
18.8 Currency Conversion 69
18.9 Contact Us 70
18.10 Disclaimer 70
[Fade out table of contents]

Table 1: Doctors by Specialty in China, 2003-2007 14
Table 2: Hospital Wards by Specialty in China, 2003 - 2007 15
Table 3: Healthcare Institutions in China, 2000-2004 16
Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2004 16
Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004 17
Table 6: China Healthcare Trade Statistics, 2001-2006 19
Table 7: China, Medical Equipment Market Comparison 30
Table 8: Diabetes Care Devices Market, Country Comparison 32
Table 9: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012 33
Table 10: Diabetes Care Devices Market, China, Portfolio Analysis 34
Table 11: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007 35
Table 12: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012 36
Table 13: Diabetes Care Devices, China, Overall Volume (Units), 2000-2012 37
Table 14: Diabetes Care Devices, China, Overall Volume (Units), Historic, 2000-2007 37
Table 15: Diabetes Care Devices, China, Overall Volume (Units), Forecast, 2007-2012 37
Table 16: Diabetes Care Devices, China, Overall Company Share by Revenue ($ mn), 2006-2007 38
Table 17: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007 39
Table 18: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 40
Table 19: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007 41
Table 20: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012 42
Table 21: Glucose Monitoring, China, Average Price ($), Historic, 2000-2007 43
Table 22: Glucose Monitoring, China, Average Price ($), Forecast, 2007-2012 43
Table 23: Glucose Monitoring, China, Distribution Share by Revenue ($ mn), 2006-2007 44
Table 24: Glucose Monitoring, China, Company Share by Revenue ($ mn), 2006-2007 45
Table 25: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Table 26: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 47
Table 27: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2000-2007 48
Table 28: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2007-2012 48
Table 29: Insulin Delivery, China, Average Price ($), Historic, 2000-2007 49
Table 30: Insulin Delivery, China, Average Price ($), Forecast, 2007-2012 49
Table 31: Insulin Delivery, China, Distribution Share by Revenue ($ mn), 2006-2007 50
Table 32: Insulin Delivery, China, Company Share by Revenue ($ mn), 2006-2007 51
Table 33: Abbott Laboratories Pipeline Products by Equipment Type 58
Table 34: Abbott Laboratories Pipeline Products By Development Stage 58
Table 35: Abbott Laboratories Pipeline Products By Therapy Area 58
Table 36: Abbott Laboratories Pipeline Products By Clinical Trials 59
Table 37: Abbott Laboratories Pipeline Products By News Summaries 59
Table 38: LifeScan, Inc. Pipeline Products by Equipment Type 60
Table 39: LifeScan, Inc. Pipeline Products By Development Stage 60
Table 40: LifeScan, Inc. Pipeline Products By Therapy Area 61
Table 41: LifeScan, Inc. Pipeline Products By News Summaries 61
Table 42: Novo Nordisk A/S Pipeline Products by Equipment Type 62
Table 43: Novo Nordisk A/S Pipeline Products By Development Stage 62
Table 44: Novo Nordisk A/S Pipeline Products By Therapy Area 62
Table 45: Currency Conversion from USD to Local Currency at 2007 Constant Rate 69

Figure 1: Total Healthcare Expenditure in China, 2000 – 2005 13
Figure 2: Medical Equipment Registration Process in China, 2007 22
Figure 3: CCC Mark Certification Process in China, 2007 24
Figure 4: China, Medical Equipment Market Comparison, 2007 29
Figure 5: Diabetes Care Devices, Revenues ($ mn) by Country, 2000-2012 31
Figure 6: Diabetes Care Devices Market, Country Comparison 32
Figure 7: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012 33
Figure 8: Diabetes Care Devices Market, China, Portfolio Analysis 34
Figure 9: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007 35
Figure 10: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012 36
Figure 11: Diabetes Care Devices, China, Overall Company Share (%), 2007 38
Figure 12: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007 39
Figure 13: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 40
Figure 14: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007 41
Figure 15: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012 42
Figure 16: Glucose Monitoring, China, Company Share (%), 2007 45
Figure 17: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Figure 18: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012 47
Figure 19: Insulin Delivery, China, Company Share (%), 2007 51
Figure 20: F. Hoffmann-La Roche Ltd., Value Chain Analysis 52
Figure 21: Abbott Laboratories, Value Chain Analysis 55
Figure 22: Becton, Dickinson and Company, Value Chain Analysis 63
Figure 23: Global Markets Direct Methodology 65
[Fade out list of tables / figures]